Suchergebnisse - "Smolen, Kali A"

PubPharm (7)

1

Quantitative proteomics and phosphoproteomics of PP2A-PPP2R5D variants reveal deregulation of RPS6 phosphorylation via converging signaling cascades

enthalten in: The Journal of biological chemistry | 2023

von Smolen, K. | Papke, C. | Swingle, M. | +6

UpdateOf: bioRxiv. 2023 Mar 27;:. - PMID 37034727

2

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors

enthalten in: Journal of visualized experiments : JoVE | 2022

von Smolen, K. | Kettenbach, A.

3

A disorder-related variant (E420K) of a PP2A-regulatory subunit (PPP2R5D) causes constitutively active AKT-mTOR signaling and uncoordinated cell growth

enthalten in: The Journal of biological chemistry | 2021

von Papke, C. | Smolen, K. | Swingle, M. | +9

4

Structural Insights into Inhibition of the Acinetobacter-Derived Cephalosporinase ADC-7 by Ceftazidime and Its Boronic Acid Transition State Analog

enthalten in: Antimicrobial agents and chemotherapy | 2020

von Curtis, B. | Smolen, K. | Barlow, S. | +6

5

1,2,3-Triazolylmethaneboronate : A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against Acinetobacter baumannii Cephalosporinase

enthalten in: ACS infectious diseases | 2020

von Caselli, E. | Fini, F. | Introvigne, M. | +9

6

Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase

enthalten in: ACS infectious diseases | 2018

von Bouza, A. | Swanson, H. | Smolen, K. | +8

7

Inhibition of Acinetobacter-Derived Cephalosporinase : Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors

enthalten in: ACS infectious diseases | 2018

von Caselli, E. | Romagnoli, C. | Powers, R. | +8

1
[1]